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Summary. People with familial history of disease often consult with genetic
counselors about their chance of carrying mutations that increase disease risk.
To aid them, genetic counselors use Mendelian models that predict whether
the person carries deleterious mutations based on their reported family history. Such models rely on accurate reporting of each member’s diagnosis and
age of diagnosis, but this information may be inaccurate. Commonly encountered errors in family history can significantly distort predictions, and thus
can alter the clinical management of people undergoing counselling, screening, or genetic testing. We derive general results about the distortion in the
carrier probability estimate caused by misreported diagnoses in relatives. We
show that the Bayes Factor that channels all family history information has
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a convenient and intuitive interpretation. We focus on the ratio of the carrier
odds given correct diagnosis vs. given misreported diagnosis to measure the
impact of errors. We derive the general form of this ratio and approximate it
in realistic cases. Misreported age of diagnosis usually causes less distortion
than misreported diagnosis. This is the first systematic quantitative assessment of the effect of misreported family history on mutation prediction. We
apply the results to the BRCAPRO model, which predicts the risk of carrying
a mutation in the breast and ovarian cancer genes BRCA1 and BRCA2.
Key words: Family History Errors; Genetic Counselling; Bayes Factor;
Measurement Error; BRCA1; BRCA2; BRCAPRO; CRCAPRO
1.

Introduction

People who are concerned that their family has a high prevalence of disease
may seek genetic counselling to assess their risk of carrying inherited genetic mutations that cause the disease (Croyle and Lerman, 1999). To aid
such people (referred to as consultands), genetic counselors employ statistical models that predict whether the consultand carries deleterious mutations
by using the consultand’s reported family history of disease. For syndromes
whose onset occurs over a lifetime (as is common in cancer), family history
is the age at which each family member developed disease, or that member’s
current age or age at death. Models that combine family history information
with knowledge of each gene’s mode of Mendelian transmission, penetrance
(probability of disease given genotype), and prevalence are called Mendelian
models. These models determine the probability that the consultand is a
mutation carrier via Bayes’s rule and Mendel’s laws (Murphy and Mutalik,
1969). The consultand’s carrier probability is a crucial component in the
2
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consultand’s decision to take a genetic test (if a test exists), to undergo frequent disease screening, or to consider prophylactic options. For the BreastOvarian Cancer Syndrome (Claus et al., 1996), the popular Mendelian model
BRCAPRO estimates the probability that a consultand carries a deleterious
mutation in the BRCA1 and BRCA2 genes, based on family history of breast
and ovarian cancer (see Berry et al., 1997 and Parmigiani et al., 1998). Another example is CRCAPRO, which computes the probability of carrying a
mutation in the genes MLH1 and MSH2 given family history of colorectal
and endometrial cancer (Chen et al., 2004).
However, Mendelian models rely on accurate knowledge of family history.
Consultands cannot always provide accurate information; sometimes they
cannot provide the required information, or mistakenly provide inaccurate
information. Error rates depend on many variables, including disease type,
age-at-diagnosis, and degree of relationship to the consultand; for example,
consultands report only 44% of the ovarian cancers in their second-degree
(2◦ ) relatives (Ziogas and Anton-Culver, 2003).
Such errors can seriously distort the carrier probability estimate. For example, consider an Ashkenazi-Jewish consultand reporting herself as cancerfree at age 50, reporting that her mother got breast cancer at age 70, but
unaware that her grandmother had ovarian cancer at age 50. Then BRCAPRO estimates her probability of carrying a BRCA mutation as 3.5%,
but her BRCAPRO probability based on correct information is 19%. This is
especially important because genetic counselors often offer genetic testing to
the consultand once the probability breeches 10% (Domchek et al., 2003).
Genetic counselors working in academia or controlled studies try to con3
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tact other relatives to verify the given information, but relatives may be deceased or otherwise difficult to contact. Furthermore, genetic counselors not
working in those settings may have limited options for verifying the given
information. Thus inaccurate family history is a reality of genetic counselling, but we are unaware of any methodological contribution addressing
this complex problem. This paper examines Mendelian models to determine
the distortion of the carrier probability by three types of misreported family
history:
1. Diagnosis incorrect, Age-at-diagnosis correct: This error results from
the consultand knowing that something happened to their relative at
that age, but not knowing what. In the example above, ovarian cancer
diagnoses are often concealed from the family. Since ovarian cancer
is often rapidly fatal, the age-at-death approximates the true age-atdiagnosis of ovarian cancer. This paper primarily concerns this error.
2. Diagnosis correct, Age-at-diagnosis incorrect: Here the consultand remembers a relative’s disease diagnosis but not their age at diagnosis.
This error also happens if the model requires age-of-onset rather than
age-of-diagnosis. Often, all that is known is an age range within which
the relative developed disease.
3. Diagnosis incorrect, Age-at-diagnosis incorrect.
This paper shows a convenient interpretation of the Bayes Factor (BF)
from Mendelian models. Defining the distortion of the estimated carrier odds
caused by errors as the ratio of the BF given correct information to the BF
given misreported information, we derive the distortion caused by the first
4
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type of error in each family member, both exactly and for a rare autosomaldominant mutation, for a general Mendelian model and for BRCAPRO. This
distortion takes the form of a hazard ratio. Misreported diagnoses usually
cause more distortion than misreported ages, so this paper focuses on this
aspect. The last two types of error are considered within BRCAPRO.
2.

Computing the Carrier Probability

Mendelian models require knowledge of which disease each relative developed
and the age when it was diagnosed, or if no disease developed, the current
age or age of death. For simplicity, assume that only one disease is involved
in the syndrome, so ci = 0, 1 indicates disease in relative i and yi is the
age of diagnosis (or current age or age at death). Let Hi = (yi , ci ) and
H = (H0 , H1 , . . .). Assume that individuals independently inherit one allele
from each parent at each autosomal locus and that the alleles are either
normal or mutated. Let γi = 0, 1 indicate carrying the genotype(s) that
confer(s) disease risk; for example, γi = 1 for a dominant trait when the
member carries at least 1 mutant allele, but for a recessive trait γi = 1
implies the relative carries two mutant alleles. The absolutely continuous
penetrance survivals S0 , S1 are the probability of surviving the disease up to
some age, given γi = 0, 1 respectively; similarly for the penetrance densities
f0 , f1 and penetrance hazards h0 , h1 . The population prevalence of γi = 1 is
π. The aim is the consultand’s carrier probability P (γ0 = 1|H).
By Bayes rule, the odds of the consultand being a carrier is a product of

5
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the prior odds in the population and the Bayes Factor:
π
P (γ0 = 1|H)
=
BF (H),
P (γ0 = 0|H)
1−π
P (H|γ0 = 1)
BF (H) =
.
P (H|γ0 = 0)
Since family history only affects the carrier probability through the Bayes
Factor (BF), it suffices to consider the effect of errors in family history on
the BF. Section 2.1 shows and interprets the BF, and later sections examine
the effect of errors on the BF.
2.1 Bayes Factor for a General Family
If all relationships between the ancestors and the descendants are via
the consultand, then conditioning on the consultand makes the ancestors
independent of the descendants. The BF breaks into contributions from
the (c)onsultand, the (a)ncestors, and the (d)escendants. Thus BF (H) =
BFc × BFa × BFd .
For the consultand, the likelihood is
P (H|γ0) = P (Y0 = y0 , C0 = c0 |γ0 ) = P (H0 |γ0 ) ∝ fγ0 (y0 )c0 Sγ0 (y0 )1−c0 ,
assuming independent non-informative censoring. The censoring mechanism
always drops out of the likelihood and will never be referred to (Katki et al.,
2004). The BF is
BFc =

f1 (y0 )c0 S1 (y0 )1−c0
P (H0 |γ0 = 1)
=
.
P (H0 |γ0 = 0)
f0 (y0 )c0 S0 (y0 )1−c0

(1)

BFc is a ratio of penetrance densities if the consultand has the disease, otherwise, it is the ratio of penetrance survivals.

6
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Assuming that Hi is independent of all other information, given that
member’s γi , then contributions to the BF from family members are channeled through the first-degree (1◦ ) relatives, i.e. parents and children. Thus
BFa is funneled through the parents, so conditioning on their genotypes
breaks the ancestors into independent contributions from mother’s side ancestors, father’s side ancestors and siblings’ families (who contribute only
through their connection to the parents). The likelihood is
!
#sibs
1
Y
X
P (Hs |γf = i, γm = j) P (Hf |γf = i)P (Hm |γm = j)P (γf = i, γm = j|γ0 ), (2)

i,j=0

s=1

where Hf is the vector of all the father’s side phenotypes, Hm is the mother’s

side phenotypes and Hs are each sibling’s side phenotypes. Let Aij be each
term in (2) when γ0 = 0 and wij = A00 A01 A10 A11 /Aij . Then
BFa =

−1
−1
−1
−1
w00
B00 + w01
B01 + w10
B10 + w11
B11
,
−1
−1
−1
−1
w00 + w01 + w10 + w11

where Bij is the BF contributed by the parents if their genotypes were known:
Bij =

P (γf = i, γm = j|γ0 = 1)
.
P (γf = i, γm = j|γ0 = 0)

Thus BFa is a weighted average of BFs that the parents would contribute if
their genotypes were known. Since their genotypes are unknown, the BF is a
weighted average of the two, with weights wij reflecting the likelihood of the
parents’ possible genotype. However, if backwards transmission of γ0 = 0
is impossible, then one of the Bij = 1/0 = ∞ and the weighted-average
interpretation breaks down.
The descendants are the kids of the consultand and their families. Their
likelihood contribution is
#kids 1
Y X

P (Hk |γk = i)P (γk = i|γ0 )

k=1 i=0

7
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where Hk are all the phenotypes within the family of kid k. Let wi (k) =
P (Hk |γk = i)P (γk = i|γ0 = 0). Then
#kids

BFd =

Y w −1 (k)B0 + w −1 (k)B0
1
0
,
−1
−1
w
(k)
+
w
(k)
0
1
k=1

where Bi = p1i /p0i = P (γk = i|γ0 = 1)/P (γk = i|γ0 = 0) are the Bayes
Factors favoring the consultand being a carrier, if the child’s carrier status
is known. Thus BFd is a weighted averaged of the BFs that children would
contribute if their genotypes are known, with weights reflecting the likelihood
of each child’s possible genotype.
Thus the BF breaks into pieces from the consultand and family. The
family contributes a weighted average of the BFs from 1◦ relatives if their
genotypes were known. For simple families, such as consultand/mother or
consultand/mother/maternal grandmother, the weights are the likelihood of
the relatives’ data given the consultand’s carrier status and the BFs that are
averaged over are the likelihoods of the mother being a carrier given the consultand’s carrier status – see the Appendix, which also provides approximate
BFs for a rare autosomal-dominant mutation. The rest of the paper shows
the distortion of BF by the three types of errors of section 1.
3.

Effect of Misreported Diagnosis

Under the first type of error (which assumes known age of diagnosis), the effect of misreported diagnosis on the BF can be summarized by a ratio of BFs,
the numerator being the BF for the family member correctly having disease
and the denominator for the family member incorrectly not having disease.
This is an underreporting error; for overreporting, the ratio is inverted.

8
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If the consultand has underreported cancer, then the BF ratio is
BF Ratio =

f1 /S1
h1
f1 /f0
=
= ,
S1 /S0
f0 /S0
h0

(3)

the hazard ratio of the mutation vs. wildtype (since age of diagnosis is known,
it is dropped as an argument). Thus errors in diagnosis are irrelevant if the
diagnoses imply equivalent hazards at the age of diagnosis. Furthermore, if
the hazards are proportional, then misreporting causes the same distortion
at any age. Since the BF factors into contributions from the consultand and
from the family, the BF ratio for the misreporting in the family is a product
of (3) with the BF ratio from the family derived below. It is most useful to
consider the effect of misreporting diagnosis in a single 1◦ or 2◦ relative.
3.1 Misreporting a 1◦ relative’s diagnosis
In a consultand/1◦ -relative family with underreported 1◦ relative’s diagnosis, then the ratio of BFs is (see Appendix for derivation of the BF)
(1)

f0 p10 + f1 p11 S0 p00 + S1 p01
h
BF Ratio =
×
= 1(1) ,
f0 p00 + f1 p01 S0 p10 + S1 p11
h0
−1
−1
(S1 pj1 ) h0 + (S0 pj0 ) h1
(1)
.
hj =
(S1 pj1 )−1 + (S0 pj0 )−1
(1)

The hj

(4)
(5)

are weighted averages of h0 , h1 . Since a ratio of weighted aver-

ages of two quantities is less than the ratio of the two quantities, then
misreporting a 1◦ relative distorts the BF less than the same misreport
in the consultand. Furthermore, the weighting depends on the inverse of
Sj pij = P (Y1 = y1 , C1 = 0, γ1 = j|γ0 = i). This is the likelihood of the
1◦ relative surviving, given the consultand. If this probability for j is small,
then the other hazard h1−j gets more weight. If the hazards are proportional,
there is still time-dependence in equation (4) since the weights depend on
9
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time through the survivals.
For a rare autosomal-dominant mutation (see Appendix equation A.1),
the BF ratio is approximately
(1)

h1

(1)

h0

≈

1+
1+

f1
f0
S1
S0

1
=
S0 + S 1



h1
S0 + S 1
h0



1
=
1 + SS10



S 1 h1
1+
S 0 h0



.

(6)

Equations (6) and (3) are the same except for the ’1+’ terms, and (6) is a
linear function of the hazard ratio, which is the effect of an underreport for
the consultand. The intercept and slope sum to one, and each are posterior
probabilities of being a non-carrier (and carrier, respectively) given being
unaffected, assuming even prior odds of being a carrier. Thus, when h1 /h0 =
(1)

(1)

1, then h1 /h0 = 1; no-distortion in the consultand is also no-distortion for
the 1◦ relative. The distortion caused by misreported diagnosis in 1◦ relatives
is less than that caused by the same misreported diagnosis in the consultand
(figure 1). At early ages of diagnosis, when S0 ≈ S1 ≈ 1, the distortion
in the BF by misreported diagnoses in 1◦ relatives is half that of the same
misreported diagnosis in the consultand. Furthermore, if the mutation is
strongly deleterious and shifts the age of onset to earlier ages (like BRCA),
then the survival ratio is small at older ages and the hazard ratio decreases
at older ages, and the distortion attenuates. Thus misreported diagnoses in
old enough 1◦ relatives cause little distortion. Intuitively, if S1 (y) ≈ 0, then
the relative has reached an age that carriers rarely reach, thus the relative
is unlikely to be a carrier. It doesn’t matter what happens at age y, just
reaching that age suffices.
[Figure 1 about here.]
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3.2 Misreporting a 2◦ Relative’s Cancer
For the consultand/1◦ -relative/2◦ -relative family in the Appendix, the BF
(2)

(2)

ratios, depending on the 1◦ relative’s status c1 , are h1 /h0 where
(2)

hi =

(f1c1 S11−c1 S1 pi1 )−1 h0 + (f0c1 S01−c1 S0 pi0 )−1 h1
.
(f1c1 S11−c1 S1 pi1 )−1 + (f0c1 S01−c1 S0 pi0 )−1

Again, this is a ratio of weighted averages of the hazards. Under the rare
autosomal-dominant mutation approximation of (A.2), the ratios are


f1
f1
1
+
1
+
f0
f0
BF (c1 = 1, c2 = 1)
1


BFratio
=
≈
f1
S1
BF (c1 = 1, c2 = 0)
1 + f 0 1 + S0


f1
S1
1
+
1
+
S0
f0
BF (c1 = 0, c2 = 1)
0

.
≈
BFratio
=
BF (c1 = 0, c2 = 0)
1 + S1 1 + S1
S0

(7)

(8)

S0

These ratios are of the form g(α1 ) = (1 + α1 (1 + A))/(1 + α1 (1 + B)) where
α1 is contributed by the 1◦ relative and (1 + A)/(1 + B) is the ratio if the 1◦
relative were misreported (equation (6)). Since 1 ≤ f (α1 ) ≤ (1 + A)/(1 + B),
the effect of misreported diagnosis in the 2◦ relative is attenuated from the
effect that the same error in the 1◦ relative would have had. Also,


f1

 (1)
(2)
1
+
α
1
+
1
f0
1
S 1 h1
h1
=
 × α1 1 +


≈
,
(2)
S0 h(1)
h0
1 + α1 1 + SS10
1 + α1 1 + SS10
0

a linear function of the BF ratio for the 1◦ relative. The intercept and slope
are less than 1, so we again have attenuation. Plugging in equation (6),


(2)
1
h1
S 1 h1

 × 1 + α 1 + α1
≈
,
(2)
S1
S
h
0
0
h0
1 + α 1 1 + S0

the BF ratio in the 2◦ relative is linear in the BF ratio for the consultand
(Figure 1). Thus, since g(α1 ) is monotone increasing, and if f1 /f0 > S1 /S0
11
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(but small enough so the rare mutation approximation (A.2) still holds; reasonable for BRCA after age 35), then misreported diagnosis in the 2◦ relative
causes greater distortion if the 1◦ relative is affected rather than unaffected.
But the change in the distortion with age of the 2◦ relative strongly depends
on the status and age of the 1◦ relative, so no simple rules can be stated.
3.3 Application to BRCAPRO
Figure 2 shows the BF ratio for underreported breast cancer diagnoses in
family members in the simple families for the BRCA1 carrier probability in
Ashkenazi Jews. The penetrances are from Chen, Iversen, et al., 2004. The
consultand is 10 and 20 years younger than the 1◦ and 2◦ relative respectively.
Each solid line is the exact BF ratio for the family and the dotted line is the
rare mutation approximation. Underreporting the consultand leads to BF
ratios of 20 at young ages and decreases to 7 at old ages (as noted in section 3,
these BF ratios are the hazard ratios). Underreporting a single 1◦ relative
leads to BF ratios that go from 7.5 to 2.5, and the lowest two lines show the
effect of underreporting a 2◦ relative fixing the 1◦ relative. The BF ratios for
each error are closely log-linear in age because the hazard ratios are closely
log-linear in age. The approximations tend to slightly overestimate the effect
of underreporting. The approximation tends to be rougher if the penetrance
density ratio is high (see Appendix), as it is at younger ages. Also, the
requirements of the approximation for 2◦ relatives are more stringent than
for 1◦ relatives (see Appendix), so the quality of the approximation depends
on the family. However, the approximation does correctly predict that BF
ratio for 2◦ relatives with affected 1◦ relatives is higher than for unaffected 1◦
relatives. For a rare mutation like BRCA, an underreporting BF ratio of just
12
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two will halve the carrier probability, so these errors can have big impact.
[Figure 2 about here.]
4.

Effect of Errors in Age of Diagnosis

Errors in age of diagnosis can be summarized by ratios of BFs, the numerator
with the BF given the true age and denominator the BF with the incorrectly
reported age. Often a consultand cannot recall the exact age, but can specify a range within which the true age lies. This is like a round-off error.
Although general results are difficult to obtain, it is easy to simulate such
errors in a specific model, such as BRCAPRO. For the simple families of the
Appendix, the two left panels of figure 3 show the distortion in the BF caused
by rounding the age of a single 1◦ relative to the nearest 30 (±15 years) and
10 (±5 years) and the two right panels of figure 3 show the effect of rounding
the age of a single 2◦ relative to the nearest 30 and 10, assuming an affected
1◦ relative with known age of diagnosis at the true age of diagnosis of the 2◦
relative. Errors of ±15 years cause a maximum distortion of 70% in the BF,
and a maximum 20% distortion for ±5 years. Similar computations show
that the BF ratio for rounding age to the nearest 30 in unaffected relatives
is no more than 1.15. Figure 4 shows the effect of simultaneous underreporting and rounding errors. Clearly, underreporting diagnosis is the more
important error, but figure 3 shows that strong rounding error can cause
meaningful distortion.
[Figure 3 about here.]
[Figure 4 about here.]
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5.

Discussion

The three types of misreported family history discussed in this paper can
seriously distort the carrier probability estimate from Mendelian mutation
prediction models. The distortion caused by misreported family history is
channelled through the ratio by which it changes the true BF. The BF is the
product of contributions from the consultand and the ancestors/descendants
that are weighted averages of the BFs that parents and children would contribute if their genotypes were known, with weights depending on the likelihood of them carrying each genotype.
Under this special structure, the BF ratios for misdiagnosis in a relative
(assuming known age of diagnosis) are ratios of weighted averages of the
mutant and wildtype penetrance hazards. These ratios are generally complicated functions involving the entire family, but can be simplified in certain
realistic cases. Assuming a rare autosomal-dominant mutation (like BRCA),
the BF ratios in higher-degree relatives are linear in the BF ratio for the
consultand and are attenuated towards one. In this case, the distortion in
the BF by misreporting the diagnosis of 1◦ relatives at young ages is half
that of underreporting the consultand, but at old enough ages, the distortion attenuates. If the penetrance density ratio is greater than the survival
ratio (like BRCA), then the effect of this error in 2◦ relatives is stronger if the
1◦ relative is affected. If the penetrance hazards are proportional (approximately true for BRCA1 and ovarian cancer), then the distortion caused by
misdiagnosis in the consultand is the same for any age of diagnosis, although
the distortion caused by this error in relatives generally depends on age.
These results were applied to BRCAPRO. The amount of distortion de14
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creases with age of relative, but also depends on the relationship to the
consultand and outcomes in other relatives. Misreporting age of diagnosis
in BRCAPRO for unaffected relatives has little effect. But the same error
in affected relatives, while not as important as misreporting diagnosis, can
have meaningful effects if the the error is strong enough. For a rare mutation
like BRCA, an underreporting BF ratio of just two will halve the carrier
probability, and figures 2 and 4 show that the distortion is often much worse.
These results can alert genetic counselors to which types of reported family history require verification, for general Mendelian models and BRCAPRO
in particular. Educating genetic counselors about these results is a major
challenge. The intuition developed under the rare-mutation approximation
could be useful for providing general guidelines. For a specific model, an easily interpretable version of the BF ratio graphs could be a handy reference
for the counselor. The next step is proposing Mendelian models that handle
misreported family history by accounting for population-based misreporting
rates, such as those reported by Ziogas and Anton-Culver (2003).
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Appendix
Bayes Factors for Simple Families
Subscripts on H, γ denote degree of relationship to consultand. Consider a
consultand-1◦ relative family. The likelihood is
P (H|γ0) = P (H0 , H1 |γ0 , γ1 = 0)P (γ1 = 0|γ0 ) + P (H0 , H1 |γ0 , γ1 = 1)P (γ1 = 1|γ0 ).
Under the usual conditional independence assumptions,
P (H0 , H1 |γ0 , γ1 ) = P (H0 |γ0 )P (H1 |γ1 ) = fγ0 (y0 )c0 Sγ0 (y0 )1−c0 fγ1 (y1 )c1 Sγ1 (y1 )1−c1 .
The backwards transmission probabilities pij = P (γ1 = j|γ0 = i) depend on
the mode of Mendelian transmission. For example, if the mode is autosomal
dominant, then p01 = π/2, p11 = (1 + π)/2. Putting these pieces together,
the likelihood is
P (H|γ0) = (fγ0 (y0 )G(y0 ))c0 (Sγ0 (y0 )g(y0 ))1−c0 ×

(f0 (y1 )G(y1 ))c1 (S0 (y1 )g(y1 ))1−c1 pγ0 0 + (f1 (y1 )G(y1 ))c1 (S1 (y1 )g(y1 ))1−c1 pγ0 1 ,
17
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and the BF is
BF (H) = BFc ×

M10 + M11
= BFc ×
M00 + M01

p10 1
p00 M01
1
M01

+
+

p11 1
p01 M00
1
M00

.

The BF breaks into a product of the BF from the consultand (BFc ) and a
contribution from the 1◦ relative that is funneled through
Mij = P (H1 , γ1 = j|γ0 = i) = P (H1 |γ1 = j)P (γ1 = j|γ0 = i).
Furthermore, the backwards transmission probability ratios p1i /p0i = P (γ1 =
i|γ0 = 1)/P (γ1 = i|γ0 = 0) are the Bayes Factors in favor of the consultand
being a carrier, if the 1◦ relative’s carrier status is known. Since it is unknown,
the BF is a weighted average of the two, with weights Mij reflecting how likely
the 1◦ relative is a carrier. Assuming a rare autosomal-dominant mutation,
the BF is approximately
1
BF ≈ BFc ×
2



f c1 S 1−c1
1 + 1c1 11−c1
f 0 S0



,

(A.1)

assuming π is rare enough so that πf1 /f0 ≈ πS1 /S0 ≈ 0.
For a consultand/1◦ relative/2◦ relative family (where the 2◦ relative is
directly related to the 1◦ relative, i.e. mother and maternal grandmother),
using the usual conditional assumptions, the likelihood is
γ1 ,γ2 =1

P (H|γ0 ) = P (H0 |γ0 ) ×

X

P (H1 |γ1 )P (H2 |γ2 )P (γ2 |γ1 )P (γ1 |γ0 ),

γ1 ,γ2 =0

and the BF is
P (H|γ0 = 1)
M10 GM0 + M11 GM1
= BFc ×
P (H|γ0 = 0)
M00 GM0 + M01 GM1
p11
p10
1
+ p01 M001GM0
p00 M01 GM1
,
= BFc ×
1
+ M001GM0
M01 GM1

BF (H) =

18

http://biostats.bepress.com/jhubiostat/paper58

where GMi = P (H2 |γ1 = i). The family’s contribution is a weighted average
of the BFs if the 1◦ relative’s carrier status is known. This is also the BF for a
family with one 1◦ and one 2◦ relative. Assuming a rare autosomal-dominant
mutation, the BF is approximately



1
f1c1 S11−c1
f1c2 S11−c2
BF ≈ BFc ×
1 + c1 1−c1 × 1 + c2 1−c2
,
2
f 0 S0
f 0 S0

(A.2)

assuming π is small relative to all pairs of products of f1 /f0 and S1 /S0 . The
recursive structure suggests how higher degree relatives are included.
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Figure 1. Bayes Factor Ratio in 1◦ and 2◦ relatives as a function of the BF
ratio in the consultand (which is the hazard ratio)
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Figure 2. Distortion of the Bayes Factor for Ashkenazi Jewish BRCA1 carrier probability from BRCAPRO by underreporting breast cancer diagnoses
in the consultand, 1◦ , and 2◦ relatives (for consultand 10,20 years younger
than 1◦ ,2◦ relatives respectively). Solid line is the exact BF ratio, dashed
line is the BF ratio based on the rare mutation approximation.
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Figure 3. Distortion of the Bayes Factor for Ashkenazi-Jewish BRCA1 carrier probability from BRCAPRO caused by rounding error in age of diagnosis
for affected 1◦ , 2◦ relatives. Rounding is to nearest 30 (±15 years) or nearest
10 (±5 years). The 2◦ relatives have the 1◦ relative known affected at the
true age of diagnosis of the 2◦ relative.
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Figure 4. Effect of underreporting diagnosis and rounding error in age
of diagnosis for affected 1◦ , 2◦ relatives on the Bayes Factor for AshkenaziJewish BRCA1 carrier probability from BRCAPRO. The top two lines are
for underreporting the 1◦ relative, and bottom two for the 2◦ relative. For the
2◦ relatives, they have 1◦ relative known affected at the true age of diagnosis
of the 2◦ relative. Solid line is rounding to nearest 10, dashed line is nearest
30.

23

Hosted by The Berkeley Electronic Press

